Eli Lilly: Sell It And Buy Novo Nordisk Instead (NYSE:LLY)

A lot has happened since I rated Eli Lilly (NYSE: LLY ) a Hold back in early August , as it appreciated by nearly 42% and reached a $1T market cap, the first in the pharmaceutical industry. WithAs a detail-oriented investor with a strong foundation in finance and business writing, I focus on analyzing undervalued and disliked companies or industries that have strong fundamentals and good cash flows. I have a particular interest in sectors such as Oil&Gas and consumer goods. Basically, anything that has been ...